Compositions and methods for silencing VEGF-a expression

MYPI2026002979A0Undetermined Publication Date: 2021-08-10ALNYLAM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026002979
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-01-22
Filing Date
2021-02-09
Publication Date
2021-08-10
Patent Text Reader

Abstract

The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting VEGF-A, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of VEGF-A. [No suitable figure]
Need to check novelty before this filing date? Find Prior Art